Biotech startups in Chengdu, China
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Zenitar | Chengdu | Series C | $86.0M | 2026-01-12 |
| New Radiomedicine Technology | Chengdu | Series E | $145.4M | 2026-04-03 |
| Qitan Technology | Chengdu | Series C | $14.1M | 2023-12-28 |
| Gachun Biotech | Chengdu | Series A | $14.1M | 2023-11-23 |
| 23Mofang | Chengdu | Series B | $15.7M | 2018-03-05 |
5 rows of the CSV in 5 of its 18 columns.
- The 39 biotech startups in Chengdu, China have raised $752.1M in total.
- 10 of them closed their most recent round in the last 12 months, $267.9M combined.
- The largest of those rounds is New Radiomedicine Technology's $145.4M Series E, dated April 2026.
- The most recent is Xianyan Biopharma's $21.8M Series A on 31 August 2026.
- Si Chuan Venture Capital is an investor in 2 of them, more than any other fund.
- Health care is the most common other sector, with 35 companies (90%).
- 21% were founded in 2020 or later; the median founding year is 2016.
- The most common team size is 11 to 50 employees (46% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
4 of 39| Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|
| New Radiomedicine Technology | New Radiomedicine Technology supplies medical isotopes in China. | Biotech | Series E | $145.4M | 2026-04-03 | $330.6M | Chengdu Science and Technology Venture Capital | 101 to 250 | 2016 |
| Zenitar | Zenitar conducts drug research and biomedical technology industrialization. | Biotech | Series C | $86.0M | 2026-01-12 | $155.7M | Si Chuan Venture Capital, Chengdu High-tech Ceyuan Capital, New Value Capital | 51 to 100 | 2019 |
| Qitan Technology | Qitan Technology develops genome sequencing technology. | Biotech | Series C | $14.1M | 2023-12-28 | Hillhouse Investment, Gaorong Capital, CDH Investments +1 | 51 to 100 | 2016 | |
| Gachun Biotech | Gachun Biotech runs an industrial platform producing active pharmaceutical ingredients and pharmaceutical intermediates. | Biotech | Series A | $14.1M | 2023-11-23 | $14.1M | BioVenture, Si Chuan Venture Capital | 11 to 50 | 2017 |
Table 1. Biotech startups in Chengdu, China: the 4 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 39.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | New Radiomedicine Technology | New Radiomedicine Technology supplies medical isotopes in China. | Biotech | Series E | $145.4M | 2026-04-03 | $330.6M | Chengdu Science and Technology Venture Capital | 101 to 250 | 2016 |
| 2 | Zenitar | Zenitar conducts drug research and biomedical technology industrialization. | Biotech | Series C | $86.0M | 2026-01-12 | $155.7M | Si Chuan Venture Capital, Chengdu High-tech Ceyuan Capital, New Value Capital | 51 to 100 | 2019 |
Table 2. Biotech startups in Chengdu, China: the 2 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Si Chuan Venture Capital | Venture capital firm | Chengdu, China | 2 | 5% | 1 | Zenitar |
| 2 | CDH Investments | Private equity firm | Kowloon City, Hong Kong | 2 | 5% | ||
| 3 | Chengdu High-tech Ceyuan Capital | Venture capital firm | Chengdu, China | 1 | 3% | 1 | Zenitar |
| 4 | New Value Capital | Private equity firm | Shenzhen, China | 1 | 3% | 1 | Zenitar |
| 5 | Chengdu Science and Technology Venture Capital | Venture capital firm | Chengdu, China | 1 | 3% | 1 | New Radiomedicine Technology |
| 6 | Royal Sea Capital | Venture capital firm | Yangpu, China | 1 | 3% | 1 | ClonOrgan |
| 7 | Gaorong Capital | Venture capital firm | Wangjing, China | 1 | 3% | ||
| 8 | Baidu Ventures | Venture capital firm | Beijing, China | 1 | 3% | ||
| 9 | Hillhouse Investment | Angel group | Singapore | 1 | 3% | ||
| 10 | BioVenture | Venture capital firm | Suzhou, China | 1 | 3% | ||
| 11 | Fenghou Capital | Venture capital firm | Beijing, China | 1 | 3% | ||
| 12 | Matrix Partners China | Venture capital firm | Beijing, China | 1 | 3% | ||
| 13 | Yahui Precision Medicine Fund | Venture capital firm | Zhaotong, China | 1 | 3% | ||
| 14 | Hillhouse Ventures | Venture capital firm | Singapore | 1 | 3% | ||
| 15 | Huimei Capital | Venture capital firm | Beijing, China | 1 | 3% |
Table 3. Biotech startups in Chengdu, China: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 35 | 90% | $738.4M |
| Hardware | 2 | 5% | $13.7M |
| Software | 2 | 5% |
Table 4. Biotech startups in Chengdu, China by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Seed | 14 | 36% | $485K |
| Series A | 14 | 36% | $21.2M |
| Series B | 8 | 21% | $13.7M |
| Series C | 2 | 5% | $86.0M |
| Series D+ | 1 | 3% | $145.4M |
Table 5. Biotech startups in Chengdu, China by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| August 2026 | 2 | 20% | $21.8M |
| May 2026 | 1 | 10% | $14.7M |
| April 2026 | 1 | 10% | $145.4M |
| January 2026 | 3 | 30% | $86.0M |
| December 2025 | 2 | 20% | |
| November 2025 | 1 | 10% |
Table 6. Biotech startups in Chengdu, China: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 7 | 18% | $267.9M |
| 2025 | 7 | 18% | $13.7M |
| 2024 | 3 | 8% | |
| 2023 | 7 | 18% | $104.9M |
| 2022 | 2 | 5% | $14.2M |
| 2021 | 2 | 5% | $12.2M |
Table 7. Biotech startups in Chengdu, China by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 1 | 3% |
| 2020 to 2022 | 7 | 18% |
| 2015 to 2019 | 21 | 55% |
| 2010 to 2014 | 3 | 8% |
| Before 2010 | 6 | 16% |
Table 8. Biotech startups in Chengdu, China by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 1 | 4% |
| 11 to 50 | 13 | 46% |
| 51 to 100 | 7 | 25% |
| 101 to 250 | 7 | 25% |
Table 9. Biotech startups in Chengdu, China by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its headquarters is in Chengdu, China. On 16 November 2026 that is 39 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 4 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 39 rows: 15 have no round amount, 0 no city and 17 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in Chengdu, China are on the list?
- 39, in the file dated 16 November 2026. 10 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 39 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.